April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
The Concentration Changes Of Vegf And Mcp-1 In The Eyes Of The Patients With Proliferative Diabetic Retinopathy. (the Second Vitrectomy Cases)
Yukio Sassa; Shigeo Yoshida; Ryo Asato; Keijiro Ishikawa; Toshihiro Kono; Tatsuro Ishibashi, IV
Author Affiliations & Notes
  • Yukio Sassa
    Ophthalmology, Fukuoka University Chikushi Hospital, Fukuoka, Japan
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • Shigeo Yoshida
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • Ryo Asato
    Ophthalmology, Fukuoka University Chikushi Hospital, Fukuoka, Japan
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • Keijiro Ishikawa
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • Toshihiro Kono
    Ophthalmology, Fukuoka University Chikushi Hospital, Fukuoka, Japan
  • Tatsuro Ishibashi, IV
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • Footnotes
    Commercial Relationships  Yukio Sassa, None; Shigeo Yoshida, None; Ryo Asato, None; Keijiro Ishikawa, None; Toshihiro Kono, None; Tatsuro Ishibashi, IV, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1269. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      The Concentration Changes Of Vegf And Mcp-1 In The Eyes Of The Patients With Proliferative Diabetic Retinopathy. (the Second Vitrectomy Cases)
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Yukio Sassa, Shigeo Yoshida, Ryo Asato, Keijiro Ishikawa, Toshihiro Kono, Tatsuro Ishibashi, IV; The Concentration Changes Of Vegf And Mcp-1 In The Eyes Of The Patients With Proliferative Diabetic Retinopathy. (the Second Vitrectomy Cases). Invest. Ophthalmol. Vis. Sci. 2011;52(14):1269.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To examine concentration changes of VEGF and MCP-1 in the vitreous obtained in the first vitrectomy compared to those in the second vitrectomy.

Methods: : Vitreous fluid was obtained from 145 individuals undergoing pars plana vitrectomy at Fukuoka University Chikushi Hospital (from April 2007 to March 2010) in accordance with Human Discarded Specimen Research Protocol approved by institutional review boards. Vitreous fluid was obtained again from 10 individuals (10 eyes) undergoing the second pars plana vitrectomy because of prolonged activity of the diabetic retinopathy. Undiluted samples were collected at the time of surgery, immediately stored at -80 °C until used. The concentration of VEGF and MCP-1 were determined with ELISA method at the same time. In each case, other treatments including triamcinolone acetonide and/or anti-VEGF antibody were not performed.

Results: : The concentrations of VEGF did not decrease at the time of the second vitrectomy (average 1.23ng/ml) compared to those (average 1.12ng/ml) at the first vitrectomy (p=0.87). The concentration of MCP-1 significantly increase at the time of the second vitrectomy (average 2.68ng/ml) compared to those (average 0.61ng/ml) at the first vitrectomy (p=0.015). The reasons for the second vitrectomy were tractional retinal detachment (4eyes), neovascular glaucoma (NVG) (3eyes), persistent vitreous hemorrhage (2eyes) and macular packer (1eye). MCP-1 increased 2 times at the concentration in the tractional retinal detachment cases (4eyes) compared to the other 6 eyes and VEGF increases 6 times at the concentration in the NVG (3eyes) compared to the other 7eyes.

Conclusions: : VEGF and MCP-1 may contribute to prolong the activity of the diabetic retinopathy. VEGF may develop NVG and MCP-1 may cause tractional retinal detachment.

Keywords: diabetic retinopathy • cytokines/chemokines • vitreoretinal surgery 
© 2011, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept